Get the Stockscreener App
4.22
1.69%
0.07
Ispecimen Inc stock is traded at $4.22, with a volume of 44,232.
It is up +1.69% in the last 24 hours and down -10.78% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$4.15
Open:
$4.15
24h Volume:
44,232
Relative Volume:
0.11
Market Cap:
$4.02M
Revenue:
$9.93M
Net Income/Loss:
$-11.10M
P/E Ratio:
-3.376
EPS:
-1.25
Net Cash Flow:
$-10.55M
1W Performance:
-8.46%
1M Performance:
-10.78%
6M Performance:
-31.47%
1Y Performance:
-62.74%
1-Day Range:
$3.94
$4.35
1-Week Range:
$3.94
$4.84
52-Week Range:
$3.41
$12.59
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
4.22 | 4.02M | 9.93M | -11.10M | -10.55M | -1.25 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Ispecimen Inc Stock (ISPC) Latest News
ISpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - Marketscreener.com
Bernstein: 'Welcome to the crypto bull marketBuy everything you can' - Investing.com
iSpecimen Inc. Reports Earnings Amid Financial Challenges - TipRanks
iSpecimen Inc. Earns Investor Attention After Launching Milestone Cancer Biospecimen Offering - The Globe and Mail
iSpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - The Globe and Mail
E.L.F. Beauty Inc (ELF-N) QuotePress Release - The Globe and Mail
ISpecimen Inc. Stock Surges After Announcing Expanded Cancer Biospecimen Offerings - Marketscreener.com
iSpecimen Inc. Stocks 48% Premarket Surge On Thursday Ignited A Regular Session Rally - The Globe and Mail
iSpecimen Emerges as Key Player in $13.5B Biospecimen Market, Shows 13.3% Growth Potential | ISPC Stock News - StockTitan
iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually - The Manila Times
iSpecimen Expands Cancer Sample Database, Projects $10M Annual Orders & 20% Growth | ISPC Stock News - StockTitan
iSpecimen Reports Third Quarter 2024 Results - The Manila Times
iSpecimen Q3 Revenue Dips Despite Cost-Cutting Push; Net Loss Narrows 32% | ISPC Stock News - StockTitan
Coinbase Global Inc Cl A (COIN-Q) QuotePress Release - The Globe and Mail
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times
iSpecimen Announces Public Offering to Support Growth - TipRanks
ISpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - Marketscreener.com
iSpecimen stock hits 52-week low at $3.41 amid market challenges By Investing.com - Investing.com South Africa
iSpecimen stock hits 52-week low at $3.41 amid market challenges - Investing.com
iSpecimen announces pricing of $5M public offering - TipRanks
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants - ForexTV.com
ISPCiSpecimen Inc. Latest Stock News & Market Updates - StockTitan
iSpecimen sets $5 million public stock offering at $3 per share - Investing.com
TSX Global Base Metals EW Index (TXBE) QuotePress Release - The Globe and Mail
Short Interest in iSpecimen Inc. (NASDAQ:ISPC) Decreases By 86.9% - MarketBeat
Whirlpool Corp (WHR-N) QuotePress Release - The Globe and Mail
Canacol Energy Ltd (CNNEF) QuotePress Release - The Globe and Mail
Specimen Validity Testing Market Report 2024Specimen - openPR
Brinker International (EAT-N) QuotePress Release - The Globe and Mail
iSpecimen Inc. (NASDAQ:ISPC) Sees Significant Increase in Short Interest - MarketBeat
How to Take Advantage of moves in (ISPC) - Stock Traders Daily
iSpecimen Regains Nasdaq compliance, faces arbitration claim By Investing.com - Investing.com South Africa
iSpecimen Regains Nasdaq compliance, faces arbitration claim - Investing.com India
iSpecimen Faces Ex-Executive’s Financial Claims, Regains Nasdaq Compliance - TipRanks
Trend Tracker for (ISPC) - Stock Traders Daily
iSpecimen secures $1M loan, appoints three board members - TipRanks
iSpecimen secures $1 million loan, revamps board - Investing.com
iSpecimen Secures $1 Million Loan; Appoints Three New Board Members - citybiz
ISpecimen Inc. Announces Board Changes - Marketscreener.com
iSpecimen Bolsters Finance with Loan and Board Revamp - TipRanks
ISPC Stock: Exploring iSpecimen Inc’s Growth - The InvestChronicle
iSpecimen Inc. (NASDAQ:ISPC) Short Interest Down 8.3% in August - MarketBeat
Investing in iSpecimen Inc (ISPC) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Ratio Revelations: iSpecimen Inc (ISPC)’s Financial Metrics in the Spotlight - The Dwinnex
ISPC Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Upcoming Stock Splits This Week (September 16 to September 20) – Stay Invested - MSN
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55% - MSN
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):